Should Amprius Technologies’ (AMPX) Record US$35 Million Reorder and Q3 Beat Prompt Investor Action?

• Amprius Technologies recently reported Q3 2025 earnings that exceeded analyst expectations, posting a smaller loss per share and much higher revenue, while also securing a record US$35 million customer reorder that was the company’s largest to date.
• This combination of strong operational results and a major reorder highlights growing commercial interest in Amprius’s SiCore battery technology and its momentum in advanced battery markets.
• We'll look at how Amprius’s record US$35 million reorder could reshape its investment story and future expectations.

This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality.

Amprius Technologies Investment Narrative Recap

To be a shareholder in Amprius Technologies, you need to believe in its ability to scale its SiCore battery technology and capture outsized opportunities in advanced aviation and drone markets. The recent record US$35 million reorder is a strong signal of commercial traction, likely reinforcing confidence in product demand, but the company’s continued reliance on a few high-value contracts still leaves its revenue base highly concentrated, making customer diversification the most important short-term catalyst and concentration risk the biggest near-term concern. Among recent announcements, the formation of the Amprius Korea Battery Alliance stands out for its relevance: connecting Amprius’ technology with South Korean manufacturing partners directly addresses scale-up and supply chain risks. This partnership could help the company mitigate dependencies on single markets and customers, supporting a more stable path as larger orders like the latest US$35 million deal become more frequent. Yet, this new momentum contrasts with the fact that over 90% of Amprius’ revenue still comes from just a handful of aviation and drone contracts, an area investors should be aware of if...

Read the full narrative on Amprius Technologies (it's free!)

Amprius Technologies' narrative projects $306.6 million revenue and $13.4 million earnings by 2028. This requires 89.8% yearly revenue growth and a $52.1 million increase in earnings from the current -$38.7 million.

Uncover how Amprius Technologies' forecasts yield a $17.17 fair value, a 59% upside to its current price.

Exploring Other Perspectives

Fair value estimates for Amprius Technologies from nine Simply Wall St Community participants span US$7.78 to US$28.91 per share. With advanced battery adoption surging but revenue dependent on a few niche sectors, your view on future customer diversification shapes how you might interpret these differing opinions.

Explore 9 other fair value estimates on Amprius Technologies - why the stock might be worth over 2x more than the current price!

Build Your Own Amprius Technologies Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Amprius Technologies research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Amprius Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Amprius Technologies' overall financial health at a glance.

Looking For Alternative Opportunities?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with financially sound penny stocks that balance risk and reward.
• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com